Skip to main content
Clinical Trials/ACTRN12617000653369
ACTRN12617000653369
Recruiting
未知

Effect of cognitive behaviour therapy on anxiety, depression and breathlessness in patients with Chronic Obstructive Pulmonary Disease (COPD): A randomised controlled trial.

Westmead hospital0 sites60 target enrollmentMay 5, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic obstructive pulmonary disease
Sponsor
Westmead hospital
Enrollment
60
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 5, 2017
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Westmead hospital

Eligibility Criteria

Inclusion Criteria

  • a) Severe or very severe COPD by Gold criteria (FEV1\<60% predicted; FEV1/FVC ratio \<70%).
  • b) Breathlessness (modified Medical Research Council dyspnea scale scores (mMRC \> 2\).
  • c) Completion of the Westmead Hospital Breathlessness Clinic within 9 months
  • d) Elevated anxiety or depression scores (Hospital Anxiety and Depression Scale \- Anxiety score \> 8 or Hospital Anxiety and Depression Scale \- Depression score\> 8\).

Exclusion Criteria

  • a) A history of a recent (\< 4 weeks) moderate to severe exacerbation of COPD, requiring hospitalisation.
  • b) Bed bound.
  • c) A diagnosis of dementia or cognitive impairment.
  • d) Insufficient proficiency in English for participation in CBT.
  • e) A current active diagnosis of cancer, other primary respiratory disease, substance abuse, other uncontrolled medical disorder.
  • f) Inability to comply with study procedures in the opinion of the investigators or the participant’s usual medical team
  • g) already receiving psychological intervention

Outcomes

Primary Outcomes

Not specified

Similar Trials